Company finalizing preparations for end of January 2026 U.S. FDA Biologics License Application (BLA) submission for OST-HER2 ...
UNIONDALE, NY / ACCESS Newswire / January 5, 2026 / Marquis Who's Who Honors Louis C. Thomason II, PhD, for his success in ...
Vietnam Investment Review on MSN
Samsung unveils 2026 hero product lineup ahead of CES
SYDNEY, Jan. 3, 2026 /PRNewswire/ -- Samsung Electronics has begun unveiling hero products that will join its 2026 line-up, ...
As the country prepares to ring in the new year, new state laws will take effect around the country on a host of issues, ...
SYDNEY, Jan. 3, 2026 /PRNewswire/ -- Samsung Electronics has begun unveiling hero products that will join its 2026 line-up, ahead of CES 2026 – the world's largest IT and consumer electronics show ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, ...
The most unsettling issue is not that the authoritarians are winning. It’s that those who should be opposing them seem to ...
Microsoft no longer officially supports Windows 10, so do this if you want to keep using your older PC securely.
SurvivorNet on MSN
The evERA Trial: A Promising Treatment Option For Patients With Estrogen Receptor-Positive (ER+), HER2-Negative (HER2-) Breast Cancer
The evERA breast cancer trial marks a turning point for some patients with a specific type of advanced breast cancer known as ...
The 36-month PFS rate for patients with del (17p) and/or TP53 mutation was 87% and for patients without del (17p) and TP53 mutation was 89%. The safety profile of BRUKINSA plus venetoclax was ...
LONGi’s base-metal pivot resets the solar cost curve, aligning with China’s materials engineering strengths and policy-driven innovation, impacting industry dynamics, ...
Members of the Texas County Memorial Hospital board of trustees approved budgets for 2026, including capital expenditures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results